Man With SMA Gets Stuck When Airline Leaves His Wheelchair Behind
https://pixabay.com/en/aircraft-vacations-sun-tourism-1362587/

Man With SMA Gets Stuck When Airline Leaves His Wheelchair Behind

Spinal muscular atrophy (SMA) occurs when the immune system attacks motor neurons, resulting in the muscles surrounding the spinal cord atrophying (degenerating). SMA is an inherited disorder that disables the…

Continue Reading Man With SMA Gets Stuck When Airline Leaves His Wheelchair Behind
Empowering Patients and Accelerating Research: It’s Everyone’s Goal in the Rare Community
https://pixabay.com/en/chain-strong-protection-1027864/

Empowering Patients and Accelerating Research: It’s Everyone’s Goal in the Rare Community

The Pulmonary Fibrosis Warriors (PF Warriors) and monARC Bionetworks teamed up today to host a Facebook Live video, sharing important information about how patients can become more involved in research…

Continue Reading Empowering Patients and Accelerating Research: It’s Everyone’s Goal in the Rare Community
First-in-Class Drug May be Coming to You, SCA Patients!
Source: https://pixabay.com/en/statistics-transparency-company-1445484/

First-in-Class Drug May be Coming to You, SCA Patients!

Biohaven Pharmaceutical Holding Company Ltd. announced at the end of last month that the company has completed enrollment in its Phase 3 clinical trial of trigriluzole in spinocerebellar ataxia (SCA)…

Continue Reading First-in-Class Drug May be Coming to You, SCA Patients!
Application Recently Submitted to FDA for New Hypoplasminogenemia Treatment
https://pixabay.com/en/excited-smiling-female-college-1280963/

Application Recently Submitted to FDA for New Hypoplasminogenemia Treatment

In April, Prometic Life Sciences Inc. announced it would be submitting a Biologics License Application to the FDA for treatment of hypoplasminogenemia. The company's therapy has already been listed with Orphan…

Continue Reading Application Recently Submitted to FDA for New Hypoplasminogenemia Treatment
Kill Thousands of Birds With One Stone Using This Alpha-1 Antitrypsin Deficiency Resource
https://pixabay.com/en/compass-navigation-rusted-navigate-1424709/

Kill Thousands of Birds With One Stone Using This Alpha-1 Antitrypsin Deficiency Resource

The goal of the Alpha-1 Foundation is ultimately to find a cure for Alpha-1 Antitrypsin Deficiency (A1AD). But along the way, they are also a resource for patients, families, and…

Continue Reading Kill Thousands of Birds With One Stone Using This Alpha-1 Antitrypsin Deficiency Resource
“Little People, Big World” Star Zach Roloff and His Experience with Achondroplasia
https://pixabay.com/en/hands-handyman-son-bebe-small-2383261/

“Little People, Big World” Star Zach Roloff and His Experience with Achondroplasia

Achondroplasia is one of those illnesses that you can’t hide. And everyone is going to have a different responses to it. Some ignore it, some will ask questions, and others…

Continue Reading “Little People, Big World” Star Zach Roloff and His Experience with Achondroplasia
This Just In: Hormone Therapy Could Help Hypopituitarism!
https://pixabay.com/en/measure-tape-measure-health-fitness-289399/

This Just In: Hormone Therapy Could Help Hypopituitarism!

Hypopituitarism affects many children with cerebral palsy. The condition causes poor growth, often delaying puberty. But there is good news for this community! A report was recently published called “Hypopituitarism…

Continue Reading This Just In: Hormone Therapy Could Help Hypopituitarism!
Why This Little Known Healthcare Law is Terrible for the Rare Disease Community
https://pixabay.com/en/health-heart-human-group-personal-2070880/

Why This Little Known Healthcare Law is Terrible for the Rare Disease Community

Few things are as frustrating and complex as the health care system in the US. Even the current President admitted to that fact. So, like many people in the rare disease…

Continue Reading Why This Little Known Healthcare Law is Terrible for the Rare Disease Community
NDA for Soft Tissue Sarcoma Goes to the US FDA with Ample Evidence
Source: https://pixabay.com/en/code-programming-hacking-html-web-820275/

NDA for Soft Tissue Sarcoma Goes to the US FDA with Ample Evidence

The biopharmaceutical research and development company CytRx Corporation, announced an exciting new update early this month involving the company’s work with aldoxorubicin, a new drug for treatment in soft tissue sarcomas.…

Continue Reading NDA for Soft Tissue Sarcoma Goes to the US FDA with Ample Evidence
Think You Can Never Have Too Much Water? Hyponatremia Says “Think Again”
https://pixabay.com/en/bottle-mineral-water-bottle-of-water-2032980/

Think You Can Never Have Too Much Water? Hyponatremia Says “Think Again”

I will freely admit: I am terrible, terrible, TERRIBLE about drinking enough water each day. Do I know it’s important? Of course I do! Do I recognize the health benefits?…

Continue Reading Think You Can Never Have Too Much Water? Hyponatremia Says “Think Again”

Editor’s Choice: Soo Many Promising Results, Advancements and Treatment Options for the Rare Disease World!

TGIF Patient Worthians! This week we have promising results on promising results. First up is news on a Dravet syndrome treatment. Second is a Lupus Nephritis drug in the works! Third…

Continue Reading Editor’s Choice: Soo Many Promising Results, Advancements and Treatment Options for the Rare Disease World!
Promising Results from a Chronic Lymphocytic Leukemia Phase 2 Trial
https://pixabay.com/en/little-girl-praying-people-wishing-1894125/

Promising Results from a Chronic Lymphocytic Leukemia Phase 2 Trial

On June 21st, Targeted Oncology posted the results from a phase 2 clinical trial for chronic lymphocytic leukemia (CLL). The trial examined the effects of combing two therapies--obinutuzumab and bendamustine.…

Continue Reading Promising Results from a Chronic Lymphocytic Leukemia Phase 2 Trial